# NTI164 Human PK Study

> **NCT06713447** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Fenix Innovation Group** · enrollment: 12 (estimated)

## Conditions studied

- Healthy
- Healthy Volunteer

## Interventions

- **DRUG:** NTI164

## Key facts

- **NCT ID:** NCT06713447
- **Lead sponsor:** Fenix Innovation Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06713447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06713447, "NTI164 Human PK Study". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06713447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*